ArticleAntimicrobial agents and chemotherapy2019

CMCdG, a Novel Nucleoside Analog with Favorable Safety Features, Exerts Potent Activity against Wild-Type and Entecavir-Resistant Hepatitis B Virus.

Nobuyo Higashi-Kuwata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.